Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Tibremciclib |
| Trade Name | |
| Synonyms | BPI-16350|BPI16350|BPI 16350 |
| Drug Descriptions |
Tibremciclib inhibits CDK4/6, potentially resulting in decreased tumor cell proliferation and antitumor activity (PMID: 40403388, PMID: 40742733). |
| DrugClasses | CDK4/6 Inhibitor 14 |
| CAS Registry Number | 2397678-18-9 |
| NCIT ID | C203165 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Fulvestrant + Tibremciclib | Fulvestrant Tibremciclib | 0 | 0 |
| Tibremciclib | Tibremciclib | 0 | 0 |